Literature DB >> 12160804

Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy.

Hideharu Funatsu1, Hidetoshi Yamashita, Hidetaka Noma, Erika Shimizu, Tatsuya Mimura, Sadao Hori.   

Abstract

PURPOSE: To ascertain whether the aqueous humor levels of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and protein can predict the postoperative exacerbation of macular edema in patients with nonproliferative diabetic retinopathy (NPDR) after phacoemulsification surgery for cataract.
SETTING: Department of Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
METHODS: This prospective study included 104 consecutive patients (104 eyes) with NPDR who had cataract surgery. The concentrations of VEGF and IL-6 in aqueous humor specimens obtained during cataract surgery were measured by enzyme-linked immunosorbent assay. Patients were followed for 6 months to assess the postoperative exacerbation of macular edema.
RESULTS: Ninety patients (87%) achieved a visual acuity of 20/40 or better. Exacerbation of macular edema was seen in 30 eyes (29%) after 6 months. Hypertension and the aqueous levels of VEGF, IL-6, and protein were significantly correlated with the exacerbation of macular edema (odds ratio 1.16, 1.33, 1.27, and 1.28, respectively). In contrast, there was no correlation between the exacerbation of macular edema and other systemic factors. Multivariate logistic regression analysis showed that the aqueous VEGF level increase of 100 pg/mL increased the macular edema after phacoemulsification surgery (odds ratio 1.53).
CONCLUSIONS: A high VEGF level in the aqueous humor predicted a significant risk for the postoperative exacerbation of macular edema. A model was developed to predict the risk exacerbation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160804     DOI: 10.1016/s0886-3350(02)01243-9

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  15 in total

1.  Comparison of VEGF level in tears post phacoemulsification between non-proliferative diabetic retinopathy and non-diabetic patients.

Authors:  Azman Azhan; Embong Zunaina; Mohamed Mahaneem; Ab Hamid Siti-Azrin
Journal:  J Diabetes Metab Disord       Date:  2021-08-20

2.  Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.

Authors:  H Funatsu; H Yamashita; H Noma; T Mimura; K Sakata; S Hori
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus.

Authors:  M Elizabeth Hartnett; Nicholas Tinkham; Lauren Paynter; Pete Geisen; Pinchas Rosenberg; Gary Koch; Kenneth L Cohen
Journal:  Am J Ophthalmol       Date:  2009-10-17       Impact factor: 5.258

4.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

Review 5.  Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema.

Authors:  Leah A Owen; M Elizabeth Hartnett
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

6.  Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery.

Authors:  Soon Il Kwon; Duck Jin Hwang; Ji Young Seo; In Won Park
Journal:  Korean J Ophthalmol       Date:  2011-07-22

Review 7.  Primary retinal cultures as a tool for modeling diabetic retinopathy: an overview.

Authors:  Andrea Matteucci; Monica Varano; Cinzia Mallozzi; Lucia Gaddini; Marika Villa; Sara Gabrielli; Giuseppe Formisano; Flavia Pricci; Fiorella Malchiodi-Albedi
Journal:  Biomed Res Int       Date:  2015-01-19       Impact factor: 3.411

8.  Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants.

Authors:  Y Yang; C Bailey; F G Holz; N Eter; M Weber; C Baker; S Kiss; U Menchini; J M Ruiz Moreno; P Dugel; A Lotery
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

9.  Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery.

Authors:  Liqun Chu; Bingsong Wang; Bing Xu; Ning Dong
Journal:  Mol Vis       Date:  2013-11-24       Impact factor: 2.367

10.  Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery.

Authors:  Ning Dong; Bing Xu; Bingsong Wang; Liqun Chu; Xin Tang
Journal:  Biomed Res Int       Date:  2015-02-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.